Effect of PUVA on immunologic and virologic findings in HIV-infected patients
Authors:
- Pirkko PuskaPPPirkko Puska
- Satu MattinenSMSatu Mattinen
- Anssi LagerstedtALAnssi Lagerstedt
- Kai KrohnKKKai Krohn
- 1 March 1991
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 24 (3) , 404-410
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Induction of Expression of Human Immunodeficiency Virus in a Chronically Infected Promonocytic Cell Line by Ultraviolet IrradiationAIDS Research and Human Retroviruses, 1989
- Activation of human immunodeficiency virus type 1 by DNA damage in human cellsNature, 1988
- Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)Journal of the American Academy of Dermatology, 1987
- Epidermal Langerhans Cells-A Target for HTLV-III/LAV InfectionJournal of Investigative Dermatology, 1987
- Inactivation of human T‐cell lymphotropic virus, type III by heat, chemicals, and irradiationTransfusion, 1986
- INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHTThe Lancet, 1985
- Cutaneous Squamous-Cell Carcinoma in Patients Treated with PUVANew England Journal of Medicine, 1984
- Reduction of the Fraction of Circulating Helper-Induced T Cells Identified by Monoclonal Antibodies in Psoriatic Patients Treated with Long-term Psoralen/Ultraviolet-A Radiation (PUVA)Journal of Investigative Dermatology, 1982
- INHIBITION OF DELAYED HYPERSENSITIVITY REACTION IN SKIN (DNCB TEST) BY 8-METHOXYPSORALEN PHOTOCHEMOTHERAPYThe Lancet, 1980
- Transient impairment of peripheral blood lymphocyte function during PUVA therapyBritish Journal of Dermatology, 1979